MA04.06 PD-1 Blockade Promotes Hyperprogressive Disease in NSCLC Through Macrophages Activation via Antibody-Fc/FcR Interaction

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.344
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-Small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

Clinical Cancer Research
Cancer ResearchOncology
2019English

MYC Promotes Tumorigenesis via Activation of CD47 and PD-L1

Cancer Discovery
Oncology
2016English

Macrophage PD-L1 Strikes Back: PD-1/PD-L1 Interaction Drives Macrophages Toward Regulatory Subsets

Advances in Bioscience and Biotechnology
2013English

Phospholipid Scramblase 1 Modulates FcR-Mediated Phagocytosis in Differentiated Macrophages

PLoS ONE
Multidisciplinary
2016English

Mechanism of Activation of Flavonoid Conjugates Through Interaction With Macrophages

Oleoscience
2017English

PD-1 Expression and Clinical PD-1 Blockade in B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Poor Outcome With Anti-Programmed Death-Ligand 1 (PD-L1) Antibody Due to Poor Pharmacokinetic Properties in PD-1/PD-L1 Blockade-Sensitive Mouse Models

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/P53 Mutant Lung Cancer

Cancers
Cancer ResearchOncology
2019English

PD-1 Blockade in GBM: Uncovering Response Clues

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy